Tesamorelin 5 on 2 off is a weekly dosing pattern used to limit tolerance and side effects. Learn how the schedule works, typical doses, and safety notes.
Tesamorelin 5 on 2 off is a weekly injection pattern in which tesamorelin is used five days in a row, followed by two consecutive days without it. The FDA-approved regimen for tesamorelin is 2 mg injected subcutaneously once daily, every day, so a 5-on, 2-off schedule is an off-label variation rather than a labeled protocol. Most people adopt it to reduce continuous pituitary stimulation, lower monthly cost, and give themselves short breaks from side effects.
What "5 On, 2 Off" Means in Practice
Tesamorelin is a growth hormone–releasing hormone (GHRH) analog, which means it signals the pituitary gland to release more growth hormone. Higher growth hormone raises IGF-1 and, over several months, can reduce visceral adipose tissue — the deep fat packed around the abdominal organs.
A typical 5-on, 2-off week looks like this: inject Monday through Friday, skip Saturday and Sunday, then restart Monday. Some users move the two rest days to fit travel or work, but the structure stays the same — five consecutive dosing days, then two consecutive days off.
A 5-on, 2-off schedule does not change the FDA-approved dosing of tesamorelin. The label calls for daily injections, and no phase 3 trial has tested a five-day-per-week version of the drug.
Why People Choose a 5-On, 2-Off Schedule
The appeal is practical as much as physiological. Common reasons users give include:
- Less pituitary overstimulation. Two days off may help the body preserve its own natural growth hormone pulses.
- Fewer injections. Ten dosing days per two weeks instead of fourteen.
- Lower cost. Less peptide used per month at the same per-vial price.
- Side-effect breaks. A short pause from water retention, joint aches, or sore injection sites.
No large randomized trial compares 5-on, 2-off with daily tesamorelin. Most support for this pattern comes from anecdotal reports and from experience with shorter-acting peptides, not from controlled clinical evidence.
Common Tesamorelin Injection Schedules at a Glance
| Schedule | Injections per week | How it works | Evidence level |
|---|---|---|---|
| Daily (FDA label) | 7 | 2 mg subcutaneously every day | Studied in phase 3 trials |
| 5 on, 2 off | 5 | Inject five days, rest two consecutive days | Off-label; anecdotal only |
| Every other day | 3–4 | Inject on alternating days | Off-label; limited data |
| Lower-dose daily | 7 | Reduced amount per injection | Not supported by FDA labeling |
Anyone changing frequency should also expect a change in total weekly exposure, which is why blood work matters more on a non-standard plan.
How Tesamorelin Compares to Other GH Peptides
People weighing a 5-on, 2-off plan usually compare tesamorelin with sermorelin, CJC-1295, and ipamorelin first, because each peptide has a different half-life, FDA status, and injection rhythm.
| Peptide | Mechanism | Approximate half-life | FDA status | Typical rhythm |
|---|---|---|---|---|
| Tesamorelin | GHRH analog | About 30 minutes | Approved as Egrifta for HIV-associated lipodystrophy | Once daily |
| Sermorelin | GHRH analog | 10–20 minutes | Not currently approved; older product discontinued | Often nightly |
| CJC-1295 with DAC | GHRH analog | Several days | Not approved | 1–2 times per week |
| Ipamorelin | Ghrelin receptor agonist | About 2 hours | Not approved | 2–3 times daily |
Side-by-side comparisons such as tesamorelin vs sermorelin vs cjc-1295 tend to focus on how long each peptide keeps growth hormone elevated. Tesamorelin produces short, pulse-like elevations, while CJC-1295 with DAC stays active for days.
Some users stack peptides instead of choosing one. A frequent question is cjc-1295 ipamorelin vs tesamorelin, since the first pairing hits two different receptors while tesamorelin acts only on the GHRH receptor. That same logic is why many users look into tesamorelin and ipamorelin as a stacked protocol.
Side Effects and Safety on a 5-On, 2-Off Plan
The most commonly reported tesamorelin side effects are injection-site reactions, joint pain, peripheral edema, and elevated blood sugar. Water retention is the complaint users mention most often, and it usually shows up in the first few weeks.
Two days off each week may ease swelling for some people, but no clinical data prove the schedule reduces edema. For practical strategies, many users research how to avoid water retention on tesamorelin before their first injection.
Tesamorelin can raise IGF-1 and blood glucose, so people with diabetes, active cancer, or pituitary disease should not use it without medical supervision. It is worth stating plainly that tesamorelin is not FDA-approved for general weight loss or anti-aging use in the United States.
What Results Do People Actually Report?
Phase 3 trials of daily 2 mg tesamorelin showed reductions in visceral fat of roughly 15–18% over 6 to 12 months. Subcutaneous fat and total body weight changed far less in those same studies.
Online experiences vary widely. Anyone reading tesamorelin reddit before and after threads will find a mix of modest fat-loss reports, water-weight complaints, and users who saw little change after several months.
Results outside the HIV lipodystrophy population are less predictable, and the drug is not a rapid fat-loss tool. Expectations should stay modest and realistic.
Legal, Cost, and Medical Considerations
Tesamorelin requires a prescription in the United States. Research-grade versions sold online are not approved for human use and may contain impurities or incorrect amounts of the active peptide.
A clinician can check IGF-1, blood glucose, and A1C before and during use. Monitoring matters even more on a 5-on, 2-off plan, because the schedule itself has not been studied.
Anyone considering tesamorelin alongside other compounds should discuss it with a healthcare professional first. Self-directed stacking raises the risk of overlapping side effects and makes it harder to identify what is causing a problem.
Frequently Asked Questions
Is tesamorelin 5 on 2 off as effective as taking it every day?
No head-to-head trial has compared 5-on, 2-off with daily tesamorelin, so the effectiveness of the reduced schedule is unproven. The only regimen studied in phase 3 trials is 2 mg injected once daily. Some users report similar results with five days per week, but that is anecdotal.
How much tesamorelin do you inject on a 5 on 2 off schedule?
Most people who follow this pattern keep the FDA-labeled 2 mg dose on each injection day and simply skip two days per week. That approach is off-label, and the total weekly exposure is about 29% lower than daily use. A prescribing clinician should set the actual dose.
Does tesamorelin cause water retention on a 5 on 2 off schedule?
Water retention and peripheral edema are among the most frequently reported tesamorelin side effects, and they can occur on any schedule. The two rest days may reduce swelling for some users, but no clinical data confirm that benefit. Reducing sodium, staying active, and checking in with a healthcare provider are reasonable first steps.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.